Navigation Links
BSP Raises $2.6 Million Dollars From Private Investors
Date:6/17/2008

TEL AVIV, Israel, June 17 /PRNewswire-FirstCall/ -- BSP Ltd., (http://www.bsp.co.il/pressall.asp) an Israeli company which develops and markets systems for non-invasive diagnosis and monitoring of Ischemic Heart Disease, announced that they successfully raised $2.6 million in a private funding round, that included existing shareholders in the company as well as new investors.

BSP developed the HyperQ(TM), a cutting-edge technology that offers highly reliable, low-cost and risk free cardiac monitoring for broad populations and allows, for the first time, effective and accurate testing for Ischemic Heart Disease - the No. 1 killer in the world.

Thousands of patients in Israel, Europe and the US have already been examined by HyperQ(TM) Stress Systems in controlled clinical studies, pilot programs and routine testing. The results have demonstrated the system's high efficiency and unmatched accuracy in the diagnosis of IHD. The HyperQ(TM) system received FDA clearance (510K), as well as the European CE marking.

The company has entered the clinical and commercial phase, during which the HyperQ(TM) Stress System will be integrated in inpatient and outpatient hospital settings, private doctor offices and major research centers.

Further applications on the company's scope; include bedside monitors for ischemic events; devices for cardiac home-care and telemedicine; and the implementation of the HyperQ(TM) technology in implantable cardiac devices.

"The completion of this round reflects our investors' ongoing confidence in our ability to meet our commercial and clinical milestones. This round will enable us to step-up the marketing and business development efforts in the US, and accelerate development of BSP's next application - the HyperQ bedside monitor," said Dr. Amir Beker, CEO of BSP.

Dr. Beker added, "The HyperQ(TM) technology is a revolutionary non-invasive so
'/>"/>

SOURCE BSP - Biological Signal Processing Ltd
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Merrimack Pharmaceuticals Raises $60 Million in Private Financing
2. Actress and Mom Lori Loughlin Raises Awareness About the Potential Dangers of Drowsy Driving During Allergy Season
3. New Study Raises Questions About Prostate Cancer Therapies Targeting Insulin-Like Growth Factor Receptor
4. Lilly CEO Praises Massachusetts Leadership in Biotech, Urges Policy Prescriptions to Help Ensure States Investment Generates Dividends and Jobs
5. Gen-Probe Reports Strong Financial Results for First Quarter 2008, Raises Full-Year Guidance
6. Sigma-Aldrich (Nasdaq: SIAL) Raises 2008 Diluted EPS Forecast by $.05 to $2.57-$2.67. Reports Q1 2008 Diluted EPS Up 14.3%; Sales Gain of 14.9%.
7. Edwards Lifesciences Reports Strong First Quarter Results and Raises 2008 Guidance
8. Baxter Reports Solid First Quarter Financial Results and Raises Full-Year Outlook
9. Stemline Therapeutics Raises $12.5 Million
10. Transave, Inc. Raises $35 Million Through Series D Convertible Preferred Stock Financing
11. Pieris Raises EUR 25 M (US$ 38 M) in Series B Financing Round
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... Cambridge, MA (PRWEB) May 28, 2015 ... provider located in Basel, Switzerland, and the ... (ACRES), a Cambridge, Massachusetts-based non-profit organization operating ... building a global system to enhance quality, ... product development and health research, are pleased ...
(Date:5/27/2015)... May 26, 2015 Research and Markets( ... "Global Breast Cancer Monoclonal Antibodies Market Outlook ... Globally, Roche seems to dominate the breast cancer ... block buster molecule, Herceptin has been able to ... found that breast cancer cells become recalcitrant and ...
(Date:5/27/2015)... , May 27, 2015  Tikcro Technologies Ltd. (OTCQB: ... March 31, 2015. Aviv Boim ... continued pre-clinical work to generate functional specific antibodies, targeting ... stage, we are encouraged by the development progress. We ... new antibodies which modulate immune checkpoints gain clinical acceptance ...
(Date:5/27/2015)... -- Northwest Biotherapeutics, Inc. (NASDAQ: NWBO ) ("NW Bio"), ... cancer, announced today that Dr. Marnix L. Bosch ... making an Industry Expert Theater Presentation at the 2015 ... on Saturday, May 30, 2015, from 3 to 4 ... Place. Dr. Bosch will provide an overview ...
Breaking Biology Technology:Clinerion and ACRES Partner on Patient Recruitment and Risk-Based Quality Management 2Clinerion and ACRES Partner on Patient Recruitment and Risk-Based Quality Management 3Global Breast Cancer Monoclonal Antibodies Market Outlook 2020 2Global Breast Cancer Monoclonal Antibodies Market Outlook 2020 3Tikcro Technologies Reports First Quarter 2015 Results 2Tikcro Technologies Reports First Quarter 2015 Results 3NW Bio To Present Overview Of DCVax-Direct Phase I Trial In Chicago This Weekend 2NW Bio To Present Overview Of DCVax-Direct Phase I Trial In Chicago This Weekend 3
... ReportsnReports announces it will carry , , Daptomycin ... Browse the complete , , Daptomycin - Comprehensive patent,search ... Market Research,Reports Browse All ... Eliminate unnecessary risk with the industry benchmark in,comprehensive patent information. ...
... nation,s long-term clean-energy future, but the technology has come ... Fukushima disaster. Indeed, many nations have called for checks ... safely. In the United States, about 20 ... the electricity from emission-free sources, including renewable technologies and ...
... Cebix Incorporated announced today that preclinical data for ... demonstrated a half-life of three days as compared to ... in nerve conduction velocity, a measure of the rate ... an animal model of diabetic peripheral neuropathy. Additionally, clinical ...
Cached Biology Technology:ReportsnReports - Daptomycin - Comprehensive Patent Search 2ReportsnReports - Daptomycin - Comprehensive Patent Search 3ReportsnReports - Daptomycin - Comprehensive Patent Search 4ReportsnReports - Daptomycin - Comprehensive Patent Search 5Berkeley scientists pioneer nanoscale nuclear materials testing capability 2Cebix's Long-Acting C-Peptide Ersatta™ has Potential in Multiple Chronic Complications of Diabetes 2Cebix's Long-Acting C-Peptide Ersatta™ has Potential in Multiple Chronic Complications of Diabetes 3
(Date:5/21/2015)... 21, 2015 The Sync Project™ , ... for health, today announced a collaborative partnership with ... will center on collaboration on original research, joint course ... in the collaboration, The Sync Project and BerkleeICE are ... Medicine" in the 2015-2016 academic year.  ...
(Date:5/19/2015)... Research and Markets ( ... the  "Genetic Testing Market Outlook 2018"  report ... ,A recent report, Genetic Testing Market Outlook ... current and future genetic testing market. A ... principles and types are covered in this ...
(Date:5/11/2015)... DAYTON, Ohio , May 11, 2015  Through a ... Ohio had a strong showing at AUVSI,s ... . These representatives of Ohio,s UAS ... domestic and abroad from all points along the UAS ecosystem. ... Dayton Development Coalition,s (DDC) Vice President for Aerospace Rich ...
Breaking Biology News(10 mins):The Sync Project Announces Partnership with Berklee College of Music's Institute for Creative Entrepreneurship 2The Sync Project Announces Partnership with Berklee College of Music's Institute for Creative Entrepreneurship 3Global Genetic Testing Market Outlook 2018 2Ohio Flies High at Unmanned '15, Sets Stage for Ohio UAS Conference 2
... and ecological sustainability of biofuels and the impact of ... America will take place on Friday, Dec. 5, in ... Neotropical Forests: Trends, Implications and Emerging Alternatives, is sponsored ... the Program in Native Species Reforestation, both joint programs ...
... Associated Professor, DSc Barbara Ann Halkier, Department of ... Life Sciences, University of Copenhagen, has been granted ... award for her excellent research into secondary metabolites, ... plants. In particular, her research has focused ...
... Company Experiences Record Revenue Growth from Operations in Third Quarter , ... bioMETRX, Inc. (OTC Bulletin Board: BMRX), a leading developer of consumer-based ... ending September 30, 2008. , , ... 430% increase over second quarter revenues of $100,000. , ...
Cached Biology News:Conference to explore sustainability of biofuels 2The Danisco Award 2008 goes to D.Sc. Barbara Ann Halkier from Faculty of Life Sciences, Copenhagen 2bioMETRX, Inc. Highlights 3rd Quarter 2008 Financial Results 2
Mouse monoclonal antibody raised against a partial recombinant AAAS. NCBI Entrez Gene ID = AAAS...
Rabbit polyclonal to MCP2 ( Abpromise for all tested applications). entrezGeneID: 6355 SwissProtID: P49873...
... A sensitive and high speed homogeneous ... phosphatase activity and for screening of inhibitors ... kit is based on a fluorescence superquenching ... radioactive label. The universal platform provides flexibility ...
... PowerPac 3000 power supply, 220-240 V, is ... liquid-phase isoelectric focusing (IEF). The system includes ... (60 ml) focusing chambers, chassis, harvesting apparatus, ... supply, 10 ml Bio-Lyte ampholytes (pH 3-10), ...
Biology Products: